SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-085762
Filing Date
2023-03-30
Accepted
2023-03-30 17:14:52
Documents
13
Period of Report
2023-03-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d802113d8k.htm   iXBRL 8-K 33924
2 EX-3.1 d802113dex31.htm EX-3.1 106462
  Complete submission text file 0001193125-23-085762.txt   301587

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA svra-20230328.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20230328_lab.xml EX-101.LAB 19503
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20230328_pre.xml EX-101.PRE 12167
7 EXTRACTED XBRL INSTANCE DOCUMENT d802113d8k_htm.xml XML 3717
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 23781749
SIC: 2834 Pharmaceutical Preparations